Contact this trialFirst, we need to learn more about you.
Anti-metabolites
Floxuridine for Pancreatic Cancer
Recruiting2 awardsPhase 2
Grand Rapids, Michigan
This trial is testing whether Floxuridine given through a hepatic artery infusion pump can improve outcomes for patients with liver metastases from pancreatic adenocarcinoma. Patients will receive standard of care chemotherapy along with the Floxuridine.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.